The MyBody-X APOE lab test analyzes the ε2, ε3, and ε4 variants of the apolipoprotein E gene. The ε4 variant is the strongest known genetic risk factor for late-onset Alzheimer's disease, but it is neither necessary nor sufficient for diagnosis. It also influences cardiovascular risk (e.g., elevated LDL cholesterol). Important: This test provides risk assessment, not a diagnosis. The evidence for the APOE4–Alzheimer's link is human-strong (large GWAS and meta-analyses), but the predictive value for individuals is limited. Lifestyle, environment, and other genes play major roles. A positive APOE4 result can cause psychological distress without proven preventive interventions. Therefore, genetic counseling before and after testing is recommended. This test is not a regulated medical diagnostic but a consumer product. Beware of overblown claims.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-524308d315e633bb8771ce26